FTSE All-Share
|
4 937,26
|
4,03
|
0,08 %
|
Analysen zu FTSE All-Share-Werten
| 28.03.24 | AstraZeneca Sell | Deutsche Bank AG | |
| 28.03.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 27.03.24 | Rio Tinto Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.03.24 | Vodafone Group Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.03.24 | HSBC Holdings Equal Weight | Barclays Capital | |
| 25.03.24 | Rio Tinto Buy | Deutsche Bank AG | |
| 25.03.24 | AstraZeneca Sell | UBS AG | |
| 25.03.24 | HSBC Holdings Neutral | UBS AG | |
| 25.03.24 | Unilever Sell | UBS AG | |
| 20.03.24 | GSK Buy | Jefferies & Company Inc. | |
| 19.03.24 | Unilever Underperform | Jefferies & Company Inc. | |
| 19.03.24 | Unilever Underweight | JP Morgan Chase & Co. | |
| 19.03.24 | Unilever Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.03.24 | Unilever Sell | UBS AG | |
| 19.03.24 | Unilever Overweight | Barclays Capital | |
| 19.03.24 | Vodafone Group Equal Weight | Barclays Capital | |
| 19.03.24 | Unilever Market-Perform | Bernstein Research | |
| 19.03.24 | Diageo Outperform | Bernstein Research | |
| 19.03.24 | AstraZeneca Sell | UBS AG | |
| 19.03.24 | Unilever Sector Perform | RBC Capital Markets | |
| 19.03.24 | GSK Buy | UBS AG | |
| 18.03.24 | Shell Overweight | Barclays Capital | |
| 18.03.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 18.03.24 | BAT Neutral | Goldman Sachs Group Inc. | |
| 15.03.24 | Vodafone Group Buy | UBS AG | |
| 15.03.24 | AstraZeneca Sell | Deutsche Bank AG | |
| 15.03.24 | Glencore Outperform | RBC Capital Markets | |
| 15.03.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 14.03.24 | Shell Neutral | UBS AG | |
| 14.03.24 | BP Buy | UBS AG | |
| 13.03.24 | BAT Neutral | UBS AG | |
| 13.03.24 | Glencore Buy | Deutsche Bank AG | |
| 12.03.24 | BAT Buy | Jefferies & Company Inc. | |
| 12.03.24 | BAT Neutral | UBS AG | |
| 11.03.24 | BAT Buy | Jefferies & Company Inc. | |
| 11.03.24 | Unilever Market-Perform | Bernstein Research | |
| 07.03.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 07.03.24 | GSK Buy | UBS AG | |
| 05.03.24 | BP Buy | UBS AG | |
| 04.03.24 | BP Buy | Jefferies & Company Inc. |
HOT STOCKS DER LETZTEN 3 TAGE
| Diageo | 1 |
| National Grid | 1 |
| GSK | 1 |
| AstraZeneca | 1 |
| London Stock Exchange | 1 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.